AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com

September 21, 2026 at 05:02 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

denmark United States

Tags

business strategy healthcare novo nordisk pharmaceuticals strategy wegovy weight loss weight-loss drugs

All Coverage

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNekJHT3lsN3JVUXUzTUg3R24xS0pySkxoRjQzclAwNWo0SFJfR1lwQUhEZWFUbG9kQmFyY1pMeGxvRmo2TWhBX0luTkkxRTZLOTk1a3JLb1p4ZTJsV1RFNWpDOFhYSHMwNWFxaXpPZUFfaW5DN1JldDhuN0ZiTUIzMUFIQi1YdkFNUFpWV0pVbm5tYzZ5NVRETGhDZ3Y5TW1LRFdlMlNfMXNLMTk5NWszS0pwQVVSVk53NmtpZHFjbFNXUQ?oc=5" target="_blank">Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs</a>&nbsp;&nbsp;<font color="#6f6f6f">reuters.com</font>

100%

Similar Stories

Related coverage based on topic and tags

Wegovy maker Novo shares slump as management grilled on pricing, M&A - Reuters

Wegovy maker Novo shares slump as management grilled on pricing, M&A Reuters

September 21, 2026 at 01:21 PM

Novo CEO says pills could capture 50% of weight-loss market by 2030 - Reuters

Novo CEO says pills could capture 50% of weight-loss market by 2030 Reuters

September 22, 2026 at 03:16 PM

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters

September 22, 2026 at 08:10 PM

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

September 22, 2026 at 11:25 AM

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT - Reuters

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT Reuters

September 23, 2026 at 04:13 AM

Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology - Reuters

Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology Reuters

September 25, 2026 at 02:14 PM